The Epidemic Within the Pandemic: Managing Complications in Populations with Obesity

Faculty

Robert F. Kushner, MD, MS, DABOM
Professor, Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine, Chicago, IL
Robert F. Kushner, MD, MS, DABOM
Professor, Departments of Medicine and Medical Education

Robert Kushner is Professor of Medicine and Medicine Education at Northwestern University Feinberg School of Medicine, and Director of the Center for Lifestyle Medicine in Chicago, IL, USA. After finishing a residency in Internal Medicine at Northwestern University, he went on to complete a post-graduate fellowship in Clinical Nutrition and earned a master’s degree in Clinical Nutrition and Nutritional Biology from the University of Chicago. Dr. Kushner is past-President of The Obesity Society (TOS), the American Society for Parenteral and Enteral Nutrition (ASPEN), the American Board of Physician Nutrition Specialists (ABPNS), and a founder and past-Chair of the American Board of Obesity Medicine (ABOM). He was awarded the 2016 Clinician-of-the-Year Award by The Obesity Society, the John X. Thomas, Jr. Best Teachers of Feinberg Award at Northwestern University Feinberg School of Medicine in 2017, and the Friend Award by the Academy of Nutrition and Dietetics Weight Management Group in 2020.

Dr. Kushner has authored over 250 original articles, reviews, books and book chapters covering medical nutrition, medical nutrition education, and obesity, and is an internationally recognized expert on the care of patients who are overweight or obese. He is author/editor of multiple books including Nutrition and Bariatric Surgery (CRC Press, 2015), “Lifestyle Medicine: A Manual for Clinical Practice” (Springer, 2016), Obesity Medicine, Medical Clinics of North America (Elsevier, 2018), Creating a Lifestyle Medicine Center (Springer, 2020), and “Primary Care: Evaluation and Management of Obesity” (Wolter Kluwer, 2022). His latest popular book is “Six Factors to Fit: Weight Loss that Works for You!” (Eat Right Press, 2020). Dr. Kushner’s research interests include medical and obesity education, and lifestyle and pharmacological approaches to obesity.

Ken Fujioka, MD
Director, Nutrition and Metabolic Research Center
Founding Director, Center for Weight Management
Scripps Clinic Department of Diabetes and Endocrine, San Diego, CA
Ken Fujioka, MD
Director, Nutrition and Metabolic Research Center

Dr. Ken Fujioka is the director of the Nutrition and Metabolic Research Center and the Center for Weight management at the Scripps Clnic in La Jolla, California. His time is divided equally between clinical research and clinical practice. Dr. Fujioka’s research includes diets, medications, bariatric surgery, medical devices, web based weight loss programs, and outcomes in obesity treatment. The Nutrition and Metabolic Research Center has completed over 100 clinical trials in obesity related areas. The Center for Weight Management is a referral based multispecialty center that includes endocrinologists, surgeons, psychologist, dietitians, exercise physiologist, and nurse practitioners. The multispecialty clinic sees over a 1,000 patients a month and is a recognized Center of Excellence treating all forms of obesity, morbid obesity, and eating disorders. Dr. Fujioka has also worked for the Medical Board for the state of California as an expert witness. In 1997 he was asked to define the standard of care in the treatment of obesity. He has published original research, as well as chapters of books and reviews. Additionally, he has worked with multiple government agencies and pharmaceutical companies on drug development and use in clinical practice.

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Obesity Medicine Physician Scientist
Massachusetts General Hospital
Associate Professor of Medicine and Pediatrics
Harvard Medical School
Boston, MA
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS

Dr. Stanford is an Associate Professor of Medicine and Pediatrics who practices and teaches at Massachusetts General Hospital (MGH)/ Harvard Medical School (HMS) as one of the first fellowship-trained obesity medicine physicians worldwide. She is among the most highly cited obesity medicine physician-scientists with over 170 peer-reviewed publications. Dr. Stanford received her BS and MPH from Emory University as an MLK Scholar, her MD from the Medical College of Georgia School of Medicine as a Stoney Scholar, her MPA from the Harvard Kennedy School of Government as a Zuckerman Fellow in the Harvard Center for Public Leadership and her executive MBA as a merit-based scholarship recipient from the Quantic School of Business and Technology. She completed her Obesity Medicine & Nutrition Fellowship at MGH/HMS after completing her internal medicine and pediatrics residency at the University of South Carolina. She has served as a health communications fellow at the Centers for Disease Control and Prevention and as a behavioral sciences intern at the American Cancer Society. Upon completing her MPH, she received the Gold Congressional Award, the highest honor Congress bestows upon America’s youth.

Dr. Stanford has completed a medicine and media internship at the Discovery Channel. An American Medical Association (AMA) Foundation Leadership Award recipient in 2005 and an AMA Paul Ambrose Award for national leadership among resident physicians in 2009, she was selected for the AMA Inspirational Physician Award in 2015. The American College of Physicians (ACP) selected her as the 2013 Joseph E. Johnson Leadership Award recipient, and the Massachusetts ACP selected her for the Young Leadership Award in 2015. She is the 2017 recipient of the HMS Amos Diversity Award and the Massachusetts Medical Society (MMS) Award for Women’s Health. In 2019, she was selected as the Suffolk District Community Clinician of the Year for the Reducing Health Disparities Award for MMS. She was chosen for The Obesity Society Clinician of the Year in 2020. In 2021, she was awarded the MMS Grant Rodkey Award for her dedication to medical students and the AMA Dr. Edmond and Rima Cabbabe Dedication to the Profession Award, which recognizes a physician who demonstrates active and productive improvement to the profession of medicine through community service, advocacy, leadership, teaching, or philanthropy. She is the 2021 Recipient of the Emory Rollins School of Public Health Distinguished Alumni Award. In 2022, the National Academy of Medicine selected her as a Scholar in Diagnostic Excellence. She was named to the 2025 Dietary Guidelines Advisory Committee by the US Department of Health and Human Services (HHS) and Agriculture (USDA).

 

Statement of Need

Obesity is increasingly recognized as a multi-causal chronic disease that leads to structural and physiological abnormalities and functional impairments. Despite the growing prevalence and substantial burden of obesity in terms of health-related quality of life (HRQoL), healthcare utilization, and healthcare costs, obesity remains under-diagnosed and under-treated. The recent recognition that obesity is associated with increased risk of morbidity and mortality with coronavirus disease 2019 (COVID-19) shines a light on the fact that obesity is characterized by higher prevalence of physiologic alterations, such as chronic inflammation and impaired respiratory function, when compared to the non-obese state.

This live and OnDemand webcast will include interactive animated 3-D models, and a live Q&A session. The discussion, led by expert faculty, will cover pathophysiological features of obesity that influence weight loss, guidelines for screening, diagnosis, and patient counseling, and how to assess efficacy and safety of available and emerging therapies for long-term treatment of obesity.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

  • Identify pathophysiological features of obesity that influence weight loss and maintenance.
  • Apply guidelines for screening, diagnosis, and patient counseling for obesity and obesity-related disorders.
  • Assess efficacy and safety of available and emerging therapies for long-term treatment of obesity.

The following learning objectives pertain only to those requesting CNE or CPE credit:

  • Identify pathophysiological features of obesity that influence weight loss and maintenance.
  • Summarize guidelines for screening, diagnosis, and patient counseling for obesity and obesity-related disorders.
  • Describe the efficacy and safety of available and emerging therapies for long-term treatment of obesity.

Financial Support

Supported by an educational grant from Novo Nordisk Inc.

Target Audience

Primary care physicians, endocrinologists, nurse practitioners, PAs, nurses, and pharmacists

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit  from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.


Dr. Kushner reports that he receives research support from Epitomee Medical. He is a consultant for Novo Nordisk and WW International, Inc.


Dr. Fujioka reports that he is a consultant for Amgen Inc.; Boehringer Ingelheim; Gelesis; Janssen Global Services, LLC; Novo Nordisk; Phenomix Sciences; Sunovion Pharmaceuticals Inc.; and Takeda Pharmaceuticals U.S.A., Inc. He is on the speakers bureau for Novo Nordisk and Takeda Pharmaceuticals U.S.A., Inc.


Dr. Stanford reports that she receives research support from Amazon. She is a consultant for Calibrate Health, Chroma Health, GoodRx, Inc., and Novo Nordisk.


Tony Graham, MD (peer reviewer) has no disclosures to report.

Warren Beckman (planning committee) has no disclosures to report.

Evan Luberger (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.


Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

 


NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-21-125-H01-P.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

 

 

TV-134-063021-68

The Epidemic Within the Pandemic: Managing Complications in Populations with Obesity
Event Date: 06/30/2021